← Back to Clinical Trials
RecruitingNCT01353547

Genes and Environment in Multiple Sclerosis

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

ConditionMultiple Sclerosis
SponsorColumbia University
Study TypeOBSERVATIONAL
PhaseN/A
Enrollment5,000
SexALL
Min Age18 Years
Max AgeN/A
Start Date2017-10-01
Completion2040-10

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The purpose of the research study is to identify the genetic, environmental and immune profiles that may increase a person's risk of developing multiple sclerosis (MS). While MS is not a disease caused by a single variation in genetic material (DNA), a single environmental factor, or a single malfunction in immune cells, there are genetic alterations, environmental exposures and immunologic factors that make the development of MS more likely. Obtaining information about who is at risk for MS will be beneficial in the future if the investigators can identify effective ways to prevent or slow down the progression of this disease.

Eligibility Criteria

Inclusion Criteria: * First Degree Relatives of Patients with MS, or * Patients who have received anti-TNFa therapy as treatment for inflammatory diseases other than MS such as Crohn's disease, psoriasis and rheumatoid arthritis, or * Patients that have been referred for an evaluation of first presentation of neurologic symptoms but do not have a diagnosis of MS * Live in the United States Exclusion Criteria: * Does not match any of the inclusion criteria

Related Trials